Multi-parametric MR-PET imaging predicts pharmacokinetics and clinical response to GDC-0084 in patients with recurrent high-grade glioma

PURPOSE: GDC-0084 is an oral, brain-penetrant small molecule inhibitor of phosphoinositide 3-kinase (PI3K) and mammalian target of rapamycin (mTOR). Since these two targets alter tumor vascularity and metabolism, respectively, we hypothesized multi-parametric MR-PET could be used to quantify the res...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Clin Cancer Res
Autors principals: Ellingson, Benjamin M., Yao, Jingwen, Raymond, Catalina, Nathanson, David A., Chakhoyan, Ararat, Simpson, Jeremy, Garner, James, Olivero, Alan, Mueller, Lars, Rodon, Jordi, Gerstner, Elizabeth R., Cloughesy, Timothy F., Wen, Patrick Y.
Format: Artigo
Idioma:Inglês
Publicat: 2020
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8204664/
https://ncbi.nlm.nih.gov/pubmed/32269051
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-19-3817
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars